| Dr Brian Douglas Smith, MD | |
|
210 Bevins Ln, Ste C, Georgetown, KY 40324-6120 | |
| (502) 868-0622 | |
| (502) 868-9097 |
| Full Name | Dr Brian Douglas Smith |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 30 Years |
| Location | 210 Bevins Ln, Georgetown, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902803489 | NPI | - | NPPES |
| 64045315 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 31662 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Health Lexington | Lexington, KY | Hospital |
| Georgetown Community Hospital | Georgetown, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baptist Health Medical Group Inc | 5597867184 | 1912 |
News Archive
DURECT Corporation (Nasdaq: DRRX) today reported that it has signed an exclusive long term excipient supply agreement with respect to REMOXY(R) with King Pharmaceuticals, Inc. (NYSE: KG). This agreement stipulates the terms and conditions under which DURECT will supply to King, based on DURECT's manufacturing cost plus a specified percentage mark-up, two key excipients used in the manufacture of REMOXY.
Shire plc, the global specialty biopharmaceutical company, today presented positive top line results of the first European phase III study of once-daily lisdexamfetamine dimesylate (LDX) in children and adolescents aged 6 to 17 years with Attention-Deficit/Hyperactivity Disorder.
"This week the International Committee of the Red Cross (ICRC) launches a global campaign - 'It's a matter of life and death' - which aims to improve security and delivery of effective and impartial health care in situations of armed conflict and other contexts of widespread violence," Vivienne Nathanson, director of professional activities at the British Medical Association, writes in a BMJ editorial.
A national shortage of critical care physicians and beds means difficult decisions for healthcare professionals: how to determine which of the sickest patients are most in need of access to the intensive care unit.
› Verified 6 days ago
| Entity Name | Baptist Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740586213 PECOS PAC ID: 5597867184 Enrollment ID: O20070228000503 |
News Archive
DURECT Corporation (Nasdaq: DRRX) today reported that it has signed an exclusive long term excipient supply agreement with respect to REMOXY(R) with King Pharmaceuticals, Inc. (NYSE: KG). This agreement stipulates the terms and conditions under which DURECT will supply to King, based on DURECT's manufacturing cost plus a specified percentage mark-up, two key excipients used in the manufacture of REMOXY.
Shire plc, the global specialty biopharmaceutical company, today presented positive top line results of the first European phase III study of once-daily lisdexamfetamine dimesylate (LDX) in children and adolescents aged 6 to 17 years with Attention-Deficit/Hyperactivity Disorder.
"This week the International Committee of the Red Cross (ICRC) launches a global campaign - 'It's a matter of life and death' - which aims to improve security and delivery of effective and impartial health care in situations of armed conflict and other contexts of widespread violence," Vivienne Nathanson, director of professional activities at the British Medical Association, writes in a BMJ editorial.
A national shortage of critical care physicians and beds means difficult decisions for healthcare professionals: how to determine which of the sickest patients are most in need of access to the intensive care unit.
› Verified 6 days ago
| Entity Name | Baptist Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518360296 PECOS PAC ID: 5597867184 Enrollment ID: O20150206000249 |
News Archive
DURECT Corporation (Nasdaq: DRRX) today reported that it has signed an exclusive long term excipient supply agreement with respect to REMOXY(R) with King Pharmaceuticals, Inc. (NYSE: KG). This agreement stipulates the terms and conditions under which DURECT will supply to King, based on DURECT's manufacturing cost plus a specified percentage mark-up, two key excipients used in the manufacture of REMOXY.
Shire plc, the global specialty biopharmaceutical company, today presented positive top line results of the first European phase III study of once-daily lisdexamfetamine dimesylate (LDX) in children and adolescents aged 6 to 17 years with Attention-Deficit/Hyperactivity Disorder.
"This week the International Committee of the Red Cross (ICRC) launches a global campaign - 'It's a matter of life and death' - which aims to improve security and delivery of effective and impartial health care in situations of armed conflict and other contexts of widespread violence," Vivienne Nathanson, director of professional activities at the British Medical Association, writes in a BMJ editorial.
A national shortage of critical care physicians and beds means difficult decisions for healthcare professionals: how to determine which of the sickest patients are most in need of access to the intensive care unit.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian Douglas Smith, MD 230 Lexington Green Cir, Ste 600, Lexington, KY 40503-3326 Ph: (859) 971-4695 | Dr Brian Douglas Smith, MD 210 Bevins Ln, Ste C, Georgetown, KY 40324-6120 Ph: (502) 868-0622 |
News Archive
DURECT Corporation (Nasdaq: DRRX) today reported that it has signed an exclusive long term excipient supply agreement with respect to REMOXY(R) with King Pharmaceuticals, Inc. (NYSE: KG). This agreement stipulates the terms and conditions under which DURECT will supply to King, based on DURECT's manufacturing cost plus a specified percentage mark-up, two key excipients used in the manufacture of REMOXY.
Shire plc, the global specialty biopharmaceutical company, today presented positive top line results of the first European phase III study of once-daily lisdexamfetamine dimesylate (LDX) in children and adolescents aged 6 to 17 years with Attention-Deficit/Hyperactivity Disorder.
"This week the International Committee of the Red Cross (ICRC) launches a global campaign - 'It's a matter of life and death' - which aims to improve security and delivery of effective and impartial health care in situations of armed conflict and other contexts of widespread violence," Vivienne Nathanson, director of professional activities at the British Medical Association, writes in a BMJ editorial.
A national shortage of critical care physicians and beds means difficult decisions for healthcare professionals: how to determine which of the sickest patients are most in need of access to the intensive care unit.
› Verified 6 days ago
Dr. Gus A Bynum, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1154a Lexington Rd, Georgetown, KY 40324 Phone: 502-868-0008 | |
Makayla Ann Kiser, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 210 Bevins Ln, Suite C, Georgetown, KY 40324 Phone: 502-868-0622 Fax: 502-868-9097 | |
Mrs. Megan Elise Disponett-lee, FNP-C Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 106 Magnolia Dr Ste 200, Georgetown, KY 40324 Phone: 502-868-0806 | |
Raymond Wechman Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1138 Lexington Rd, Ste 130, Georgetown, KY 40324 Phone: 502-867-0222 Fax: 502-867-0420 | |
Dr. Ivan David Morrin, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 210 Bevins Ln, Ste C, Georgetown, KY 40324 Phone: 502-868-0622 Fax: 502-868-9097 | |
Henry R Preston, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1138 Lexington Road Suite 130, Georgetown, KY 40324 Phone: 502-867-0222 Fax: 502-867-0420 | |
Nicholas Brett Smith, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1502 Oxford Dr Ste 100, Georgetown, KY 40324 Phone: 502-570-3785 |